Canadian Hematology Conference 2020

Conférence Canadienne sur l’Hématologie 2020

We are celebrating the 10th Annual Canadian Hematology Conference.

CHC is going virtual this year!

 

It will be held on a virtual streaming platform on October 1st, 2nd and 3rd.
The CHC Conference button will activate on October 1st
Access the Conference!

About CHC 2020

CHC is the largest multi-disciplinary hematological conference across Canada. It brings together a pan-Canadian and International Faculty to showcase cutting-edge research and developments in the field of hematology. This meeting covers a breadth of topics, including (but not limited to): Plasma Cell Dyscrasias, Non-Hodgkin’s Lymphoma, Hodgkin’s Disease, Chronic Lymphocytic Leukemia, Immunotherapy, Translational Science, Leukemia & MDs.

Dr. John Kuruvilla (Princess Margaret Cancer Centre) and Dr. Peter Anglin (Stronach Regional Cancer Centre) will co-chair this event. CHC 2020 is open to Canadian hematology professionals, including residents, nurses, pharmacists, and specialists who have an interest in hematology.

Date

Thursday, October 1st
Friday, October 2nd
Saturday, October 3rd

Time

Thursday:  12 pm – 5pm EST
Friday:  12 pm – 5pm EST
Saturday:  10 am – 3 pm EST

Register to Access

• Leading clinical presentations
• Panelist discussions
• First access to clinical slide decks
• Follow-up Q&A with CHC speakers
• Year-round access to recorded CHC 2020 presentations

Event Chairs

Dr. John Kuruvilla
(Princess Margaret Cancer Centre)

Dr. Peter Anglin
(Stronach Regional Cancer Centre)

Agenda

Thursday, October 1st

Plasma Cell Dyscrasias

News and Developments in Amyloidosis
Dr. Chris Venner – Cross Cancer Institute

Myeloma 2020 and Beyond 
Dr. Keith Stewart – Princess Margaret Cancer Centre

Treatment of Relapsed Refractory Multiple Myeloma in the Canadian Landscape
Dr. Kevin Song – BC Cancer

Panel Discussion 1 & 2

Chronic Lymphocytic Leukemia

Where are we headed in CLL 
Dr. Michael Hallek – Uniklinik zu Köln (Cologne, Germany)

Current Review of Frontline CLL in Canada
Dr. Graeme Fraser – Juravinski Cancer Centre

Relapse CLL in 2020
Dr. Carolyn Owen – University of Calgary

Panel Discussion 

Immunotherapy

The Challenges Ahead: A Translational Science Perspective on Immunotherapy
Rob Laister, Translational Scientist, PhD – Princess Margaret Cancer Centre

Cell Therapy
Dr. Ronan Foley – Juravinski Cancer Centre

Antibody Based Immunotherapy
Dr. John Kuruvilla – Princess Margaret Cancer Centre

Panel Discussion 

Friday, October 2nd

Non-Hodgkin Lymphoma I

Primer on CAR T in DLBCL in 2020
Dr. Frederick Locke – Moffitt Cancer Center (Florida, USA)

Relapsed Follicular NHL: A Therapeutic Challenge
Dr. Michael Crump – Princess Margaret Cancer Centre

The Use of RT in NHL in Canada: Evolving Paradigms
Dr. Richard Tsang – Princess Margaret Cancer Centre

Panel Discussion 

Leukemia & MDS

AML in 2020: Evolving Therapeutics that are Changing Therapy
Dr. Eunice Wang – Roswell Park Comprehensive Cancer Center (New York, USA)

MDS Management in Canada in 2020
Dr. Rena Buckstein – Odette Cancer Centre – Sunnybrook Health Sciences

Reviewing MPNs in 2020: A Practical and Therapeutic Approach
Dr. Vikas Gupta – Princess Margaret Cancer Centre

Panel Discussion 

Translational Science

Towards Biology – Informed Management of B-Cell Lymphoma
Dr. Robert Kridel – Princess Margaret Cancer Centre

Immunoprofiling for the Clinician: Lessons from Cell Therapy
Dr. Marcus Butler – Princess Margaret Cancer Centre

Panel Discussion 

Saturday, October 3rd

Non-Hodgkin Lymphoma II

Mantle Cell Lymphoma: Current Standards and Future Perspectives 
Dr. Martin Dreyling – LMU Hospital (Munich, Germany)

Current Management Approaches to Patients with non-MALT Marginal Zone Lymphoma
Dre Catherine Thieblemont – Hôpital Saint-Louis (Paris, France)

Gastric MALT Lymphoma: Current Approach
Dr. Emanuele Zucca – Oncology Institute of Southern Switzerland (Bellinzona, Switzerland)

Treatment Landscape of Waldenström Macroglobulinemia
Dr. Steve Treon – Dana Farber Cancer Institute (Massachusetts, USA)

PET-Pearls and PET-falls in Follicular Lymphoma
Dr. Judith Trotman – Concord Repatriation Hospital (Sydney, Australia)

Panel Discussion 

Hodgkin Lymphoma

Limited Stage Hodgkin’s Lymphoma in 2020
Dr. Martin Hutchings – Rigshospitalet (Copenhagen, Denmark)

Advanced Hodgkin’s Lymphoma in 2020: A Practical Approach Based on Today’s Data
Dr. Jonathan Friedberg – Wilmot Cancer Institute (New York, USA)

How we treat R/R-cHL in Canada in 2020
Dr. John Kuruvilla – Princess Margaret Cancer Centre

Radiation Therapy in Hodgkin Lymphoma 2020: Balancing Risks
Dr. David Hodgson – Princess Margaret Cancer Centre

Panel Discussion 

Access to Innovation and closing remarks

Thank You to our Sponsors!

Check out the CHC 2020 event page on Facebook to connect with other attendees!